• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中值滤过膜对并发急性肾损伤的脓毒症患者促炎细胞因子和氧化标志物水平的影响。

Effects of Medium Cutoff Membranes on Pro-Inflammatory Cytokine and Oxidative Marker Levels in Patients with Sepsis Who Developed Acute Kidney Injury.

机构信息

Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.

Department of Nephrology, Ankara City Hospital, Ankara, Turkey.

出版信息

Blood Purif. 2022;51(9):772-779. doi: 10.1159/000519881. Epub 2021 Nov 23.

DOI:10.1159/000519881
PMID:34814149
Abstract

INTRODUCTION

There is insufficient data on the role of the medium cutoff (MCO) membranes in the clearance of pro-inflammatory cytokines and oxidant radicals in patients with sepsis requiring hemodialysis.

METHODS

The study consisted of 38 septic patients who developed acute kidney injury (AKI) and who were scheduled to undergo 2 sessions of hemodialysis. Nineteen patients underwent their first dialysis session with the MCO membrane and 19 patients with the high-flux (HF) membrane. In the second session, the membranes were switched. Pro-inflammatory cytokine and oxidative marker levels were measured in blood samples obtained before and after both dialysis sessions. Reduction ratios were compared for the 2 types of hemodialysis membranes.

RESULTS

After the first session, there was a greater reduction in tumor necrosis factor (TNF)-α with the MCO membrane (28.2 ± 21.1 vs. 8.0 ± 6.6, p = 0.001). After the second session, there was a greater reduction in interleukin (IL)-6 (27.8 ± 26.5 vs. 5.9 ± 13.3, p = 0.003) and IL-1β (20.5 ± 21.1 vs. 4.0 ± 6.5, p = 0.004) with the MCO membrane. When the first and second sessions of all 38 patients were compared, the reductions in TNF-α, IL-6, and IL-1β were consistently greater for MCO than HF (p = 0.001, p = 0.006, p < 0.001, respectively). The reductions in total antioxidant status, total oxidant status, and myeloperoxidase were not statistically different for the 2 types of dialysis membranes.

CONCLUSIONS

MCO membrane was superior to HF membrane in the removal of cytokines in septic patients with AKI. However, a similar effect was not observed for oxidative stress markers.

摘要

简介

在需要血液透析的脓毒症患者中,关于中分子截止(MCO)膜在清除促炎细胞因子和氧化剂自由基方面的作用,数据不足。

方法

本研究纳入了 38 例发生急性肾损伤(AKI)并计划接受 2 次血液透析的脓毒症患者。19 例患者首次透析采用 MCO 膜,19 例患者采用高通量(HF)膜。在第二次透析中,两种透析膜进行了交换。在两次透析前后,采集血样测量促炎细胞因子和氧化标志物水平。比较两种血液透析膜的降低率。

结果

首次透析后,MCO 膜对肿瘤坏死因子(TNF)-α的降低作用更大(28.2 ± 21.1 比 8.0 ± 6.6,p = 0.001)。第二次透析后,MCO 膜对白细胞介素(IL)-6(27.8 ± 26.5 比 5.9 ± 13.3,p = 0.003)和 IL-1β(20.5 ± 21.1 比 4.0 ± 6.5,p = 0.004)的降低作用更大。比较所有 38 例患者的第一次和第二次透析时,MCO 膜在降低 TNF-α、IL-6 和 IL-1β方面的作用均优于 HF 膜(p = 0.001、p = 0.006、p < 0.001)。两种透析膜对总抗氧化状态、总氧化状态和髓过氧化物酶的降低作用无统计学差异。

结论

在脓毒症合并 AKI 患者中,MCO 膜在清除细胞因子方面优于 HF 膜。然而,对于氧化应激标志物,未观察到类似的效果。

相似文献

1
Effects of Medium Cutoff Membranes on Pro-Inflammatory Cytokine and Oxidative Marker Levels in Patients with Sepsis Who Developed Acute Kidney Injury.中值滤过膜对并发急性肾损伤的脓毒症患者促炎细胞因子和氧化标志物水平的影响。
Blood Purif. 2022;51(9):772-779. doi: 10.1159/000519881. Epub 2021 Nov 23.
2
Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study.中通量和高通量血液透析患者血液中尿毒症毒素水平的比较:希思利哈米迪耶埃特法尔的 Theranova(THE SHE)随机对照研究。
Blood Purif. 2020;49(6):733-742. doi: 10.1159/000508061. Epub 2020 Jul 7.
3
Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study).在使用 EMiC2 过滤器进行肾脏替代治疗时,清除脓毒症急性肾损伤患者的炎症细胞因子(Clic-AKI 研究)。
Crit Care. 2021 Jan 28;25(1):39. doi: 10.1186/s13054-021-03476-x.
4
Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.中截流(MCO)膜可减轻慢性透析患者的炎症——一项随机对照临床试验
PLoS One. 2017 Jan 13;12(1):e0169024. doi: 10.1371/journal.pone.0169024. eCollection 2017.
5
Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients.持续静脉-静脉血液滤过联合透析可清除脓毒症患者循环中的细胞因子。
Crit Care Med. 1993 Apr;21(4):522-6. doi: 10.1097/00003246-199304000-00011.
6
Removal of middle molecules with medium cutoff dialyzer in patients on short frequent hemodialysis.使用中分子截留型透析器行短频血液透析清除中分子物质。
Hemodial Int. 2021 Apr;25(2):180-187. doi: 10.1111/hdi.12906. Epub 2020 Nov 22.
7
Clinical Assessment of Continuous Hemodialysis with the Medium Cutoff EMiC®2 Membrane in Patients with Septic Shock.中分子量 cutoff EMiC®2 膜连续性血液透析在感染性休克患者中的临床评估。
Blood Purif. 2022;51(11):912-922. doi: 10.1159/000522321. Epub 2022 Mar 9.
8
Antioxidant and oxidative stress indices in dialysis-dependent acute renal failure.依赖透析的急性肾衰竭中的抗氧化及氧化应激指标
Blood Purif. 2003;21(3):213-9. doi: 10.1159/000070692.
9
In Vitro Dialysis of Cytokine-Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity.使用高截留和中截留膜对富含细胞因子的血浆进行体外透析可降低其促钙化活性。
Artif Organs. 2017 Sep;41(9):803-809. doi: 10.1111/aor.12884. Epub 2017 May 19.
10
Enhanced vascular endothelial growth factor and inflammatory cytokine removal with online hemodiafiltration over high-flux hemodialysis in sepsis-related acute kidney injury patients.在脓毒症相关急性肾损伤患者中,与高通量血液透析相比,在线血液透析滤过可增强血管内皮生长因子和炎性细胞因子的清除。
Ther Apher Dial. 2013 Oct;17(5):557-63. doi: 10.1111/1744-9987.12016. Epub 2013 Feb 17.

引用本文的文献

1
Investigation of APE1 and OGG1 expression in chronic hemodialysis patients.APE1 和 OGG1 在慢性血液透析患者中的表达研究。
Mol Biol Rep. 2024 Jan 18;51(1):144. doi: 10.1007/s11033-023-09152-3.
2
Medium cut-off dialyzer for middle molecular uremic toxins in AKI and chronic dialysis.中分子尿毒症毒素的中截留量透析器在急性肾损伤和慢性透析中的应用。
J Nephrol. 2024 Jan;37(1):23-37. doi: 10.1007/s40620-023-01771-0. Epub 2023 Oct 16.
3
Investigation of XPD, miR-145 and miR-770 expression in patients with end-stage renal disease.探讨终末期肾病患者 XPD、miR-145 和 miR-770 的表达。
Mol Biol Rep. 2023 Aug;50(8):6843-6850. doi: 10.1007/s11033-023-08608-w. Epub 2023 Jul 1.